• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在摄入环磷酰胺15年后膀胱同时发生移行细胞癌、鳞状细胞癌和腺癌。

Simultaneous occurrence of transitional, squamous and adenocarcinoma of the bladder after 15 years of cyclophosphamide ingestion.

作者信息

Chodak G W, Straus F W, Schoenberg H W

出版信息

J Urol. 1981 Mar;125(3):424-6. doi: 10.1016/s0022-5347(17)55061-2.

DOI:10.1016/s0022-5347(17)55061-2
PMID:7206101
Abstract

We report on a patient who had a urothelial tumor with tri-differentiation into transitional squamous and adenocarcinoma after ingestion of 285 gm. cyclophosphamide during a 15-year-period. The possibility is again raised that the use of high doses of this drug over long periods may be associated with an increased incidence of carcinoma of the bladder. Frequent cystoscopic examinations may be warranted in patients who have received large cumulative amounts of the drug

摘要

我们报告了一名患者,该患者在15年期间摄入285克环磷酰胺后发生了具有移行、鳞状和腺癌三重分化的尿路上皮肿瘤。长期使用高剂量这种药物可能与膀胱癌发病率增加相关的可能性再次被提出。对于接受了大量累积剂量该药物的患者,可能有必要进行频繁的膀胱镜检查。

相似文献

1
Simultaneous occurrence of transitional, squamous and adenocarcinoma of the bladder after 15 years of cyclophosphamide ingestion.在摄入环磷酰胺15年后膀胱同时发生移行细胞癌、鳞状细胞癌和腺癌。
J Urol. 1981 Mar;125(3):424-6. doi: 10.1016/s0022-5347(17)55061-2.
2
Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener granulomatosis.环磷酰胺诱发韦格纳肉芽肿病患者的膀胱炎和膀胱癌。
Ann Intern Med. 1996 Mar 1;124(5):477-84. doi: 10.7326/0003-4819-124-5-199603010-00003.
3
Uroepithelial carcinoma in association with cyclophosphamide ingestion.与环磷酰胺摄入相关的尿路上皮癌。
J Urol. 1981 Oct;126(4):544-5. doi: 10.1016/s0022-5347(17)54619-4.
4
[Urothelial carcinoma of the bladder following cyclophosphamide therapy].环磷酰胺治疗后发生的膀胱尿路上皮癌
Z Urol Nephrol. 1984 Jan;77(1):7-9.
5
Squamous cell carcinoma of the bladder associated with cyclophosphamide therapy for Wegener's granulomatosis: a report of 2 cases.与环磷酰胺治疗韦格纳肉芽肿相关的膀胱鳞状细胞癌:2例报告
J Urol. 1993 Mar;149(3):588-9. doi: 10.1016/s0022-5347(17)36156-6.
6
Cyclophosphamide treatment of systemic lupus erythematosus: risk of bladder cancer exceeds benefit.环磷酰胺治疗系统性红斑狼疮:膀胱癌风险超过益处。
Br Med J (Clin Res Ed). 1982 Apr 17;284(6323):1160-1. doi: 10.1136/bmj.284.6323.1160.
7
[Cyclophosphamide induced urinary bladder and renal pelvic tumor--a case report].[环磷酰胺诱发膀胱及肾盂肿瘤——病例报告]
Nihon Hinyokika Gakkai Zasshi. 1998 Jul;89(7):674-7. doi: 10.5980/jpnjurol1989.89.674.
8
Urothelial carcinoma after cyclophosphamide therapy.
J Urol. 1983 Jan;129(1):143-4. doi: 10.1016/s0022-5347(17)51964-3.
9
Bladder cancer following administration of cyclophosphamide.
Urology. 1980 Aug;16(2):145-8. doi: 10.1016/0090-4295(80)90068-0.
10
Evidence for cyclophosphamide-induced transitional cell carcinoma in a renal transplant patient.
J Urol. 1988 Nov;140(5):1009-11. doi: 10.1016/s0022-5347(17)41912-4.

引用本文的文献

1
Cyclophosphamide is contraindicated in patients with a history of transitional cell carcinoma.有移行细胞癌病史的患者禁用环磷酰胺。
Clin Rheumatol. 2005 Aug;24(4):319-23. doi: 10.1007/s10067-004-1032-2. Epub 2004 Dec 1.
2
Comparative activity of ifosfamide and cyclophosphamide.异环磷酰胺与环磷酰胺的活性比较
Cancer Chemother Pharmacol. 1986;18 Suppl 2:S1-9. doi: 10.1007/BF00647438.